(NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets, and home to the largest and most liquid markets to trade energy derivatives, ...
Lovell Minnick Partners ("Lovell Minnick"), a private equity firm focused on investments in financial services, business services, and related technology companies, today announced that its portfolio ...
ProPak China 2026, the 31st International Processing and Packaging Exhibition, is scheduled to be held at the National Exhibition and Convention Center (NECC, Shanghai) from June 15 to 17, 2026.
Lambda, The Superintelligence Cloud, today announced a partnership with Hudson River Trading (HRT), a leading quantitative trading firm, to accelerate HRT's trading research and development. Lambda is ...
Camunda today announced ProcessOS, a new intelligence layer for its agentic orchestration platform. The announcement was made at the annual CamundaCon, the largest global agentic ...
Tyler Technologies, Inc. (NYSE: TYL) today announced the closing of $1,437,500,000 aggregate principal amount of its 0.50% Convertible Senior Notes due 2031 (the "Notes"), including the exercise in ...
TRUEiGTECH, a proven name in sweepstakes casino software development, today announced the launch of TIGSweepstakes, a ...
ZTE provides an in-depth analysis of the industrial value of the two-way integration of AI and networks ZTE continues to consolidate its presence in Latin America, and deploy green, efficient, and ...
Calix, Inc. (NYSE: CALX) is an AI and cloud platform company that helps service providers accelerate exceptional experiences to subscribers and communities. Through Calix One, the world's leading ...
Hercules' Board of Directors maintains a variable distribution policy with the objective of distributing four quarterly distributions in an amount that approximates 90% to 100% of the Company's ...
Submitted a Marketing Authorization Application to the European Medicines Agency for AVT16 and AVT80, proposed biosimilars to Entyvio ® (vedolizumab) Commenced a pivotal efficacy and safety study for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results